CUT THROUGH THE CLUTTER
agency: AbelsonTaylor
brand: Azor
client: Daiichi Sankyo
photo from left: Melissa Bauer, account supervisor • Mark Wasserman, associate creative director, copy • Joanne Casey, senior copywriter • Natalie Sandstedt, account director • Brian Wheatley, associate creative director, art • Jane Betz, senior art director
With its striking use of color and powerful imagery, AbelsonTaylor's campaign for Azor visually captures its unique mechanism of action—two antihypertensive agents working together to lower blood pressure.
Using Douglas Fraser's retro-modern art style to capture the power and strength of the drug, AT created a unique branding style that carries through to the sales material and patient information.
Rather than focus on lowering blood pressure, the creative team concentrated on "cutting" hypertension, which they felt was a more aggressive sound bite for the Azor sales reps.
The strength of the artwork stands up to the power message. But AT also gets a vote for accuracy: The section of the sphyg that the two workers are sawing is actually the point at which blood pressure is supposed to be.
"It is no secret that the hypertension market is very crowded," says AT's Natalie Sandstedt. "We needed something that was going to stand out and pop, and I think the imagery working on the red background helps solve that problem."
Azor debuted in the market in October, along with this launch ad. According to AT, the journal ads tested very well with physicians and received total buy-in from sales reps.
HOME ›› NEXT AGENCY
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.